A doctor once told a patient's son, offhand: "too bad she's not Chinese — she could just go to a pharmacy and buy it." That sentence is the whole problem. Whether a life-extending treatment is available to you should not depend on which pharmacy is within walking distance of your passport.
Patients and families are already solving this themselves — sharing contacts, comparing trial listings, booking flights. They do it with incomplete information and no way to tell a regulated therapy from an unproven one. This site exists to close that gap: accurate, sourced, independent information about what is genuinely approved in China, what it targets, and how patients legally access it.
No payment from pharmaceutical companies, hospitals or facilitators for listings or placement. If that ever changes, it will be disclosed prominently on every affected page.
Not to patients, not to clinicians, not by mail. Any revenue we ever earn comes from information and coordination services, never from the price of a drug.
Every data set carries a "last reviewed" date. Approval status changes quarterly; stale data is worse than no data, so we would rather show you how old our information is than pretend it is timeless.
If we publish something wrong, we fix it and note the correction and its date. Tell us if you spot an error.
Realistic response rates, real risks, real costs. A treatment that works for half of the patients who take it is still worth knowing about — but you deserve to hear "half", not "works".
We inform; treating physicians decide. We will not tell you to stop or change a prescribed treatment.